Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer
Article first published online: 18 FEB 2013
Published 2013. This article is a U.S. Government work and is in the public domain in the USA.
Volume 111, Issue 8, pages 1269–1280, June 2013
How to Cite
Dahut, W. L., Madan, R. A., Karakunnel, J. J., Adelberg, D., Gulley, J. L., Turkbey, I. B., Chau, C. H., Spencer, S. D., Mulquin, M., Wright, J., Parnes, H. L., Steinberg, S. M., Choyke, P. L. and Figg, W. D. (2013), Phase II clinical trial of cediranib in patients with metastatic castration-resistant prostate cancer. BJU International, 111: 1269–1280. doi: 10.1111/j.1464-410X.2012.11667.x
- Issue published online: 28 MAY 2013
- Article first published online: 18 FEB 2013
- National Institutes of Health. Grant Number: HHSN261200800001E
- Center for Cancer Research, NCI, National Institutes of Health. Grant Number: NCT00436956
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!